PHAT Financials
Phathom Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$13.19
Market Cap
$1.00B
EPS
$-3.03
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$55.25M
Gross Profit
-
Operating Income
-
Net Income
$-334.33M
EPS (Diluted)
$-5.29
Balance Sheet Highlights
Total Assets
$378.32M
Total Liabilities
$631.90M
Shareholders Equity
-
Cash & Equivalents
$297.26M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-266.77M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
87.1%
Operating Margin
-0.1%
Net Margin
-1.3%
ROE
-34.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PHAT revenue?
PHAT's most recent quarterly revenue was $55.25M. Annual revenue can be calculated by summing the four most recent quarters.
Is PHAT profitable?
PHAT reported a loss of $334.33M in the most recent quarter. The net profit margin is -1.3%.
What is PHAT market cap?
PHAT has a market capitalization of $1.00B, making it a small-cap stock.
Does PHAT have debt?
View PHAT's balance sheet for debt information.
What is PHAT cash flow?
Cash flow data is available in the full financial statements.